Pronađeno: 1-4 / 4 radova

Autori: Kim Tae Won

>> Filter: Samo Article i Review

>> Sve godine

Naslov Final Analysis of Outcomes and RAS/BRAF Status in a Randomized Phase 3 Study of Panitumumab and Best Supportive Care in Chemorefractory Wild Type KRAS Metastatic Colorectal Cancer (Article)
Autori Kim Tae Won Elme Anneli Park Joon Oh Udrea Anghel Adrian Kim Sun Young Ahn Joong Bae Valencia Ricardo Villalobos Krishnan Srinivasan Manojlovic Nebojsa S  Guan Xuesong Lofton-Day Catherine Jung A Scott Vrdoljak Eduard 
Info CLINICAL COLORECTAL CANCER, (2018), vol. 17 br. 3, str. 206-214
Projekat Amgen Inc
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Final results from a phase III trial evaluating panitumumab (pmab) plus best supportive care (BSC) vs BSC in chemorefractory wild-type (WT) KRAS exon 2 and WT RAS metastatic colorectal cancer (mCRC). (Meeting Abstract)
Autori Kim Tae Won ... Kusic Zvonko ... Manojlovic Nebojsa S  ... (broj koautora 16) 
Info JOURNAL OF CLINICAL ONCOLOGY, (2016), vol. 34 br. 15, Suppl. S, str. -
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov A phase 3 trial evaluating panitumumab plus best supportive care vs best supportive care in chemorefractory wild-type KRAS or RAS metastatic colorectal cancer (Article)
Autori Kim Tae Won ... Manojlovic Nebojsa S  ... (broj koautora 16) 
Info BRITISH JOURNAL OF CANCER, (2016), vol. 115 br. 10, str. 1206-1214
Projekat Amgen Inc.
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov An open label, randomized phase III trial evaluating the treatment (tx) effects of panitumumab (pmab) plus best supportive care (BSC) versus BSC in chemorefractory wild-type (WT) KRAS exon 2 metastatic colorectal cancer (mCRC) and in WT RAS mCRC. (Meeting Abstract)
Autori Kim Tae Won ... (broj koautora 16) 
Info JOURNAL OF CLINICAL ONCOLOGY, (2016), vol. 34 br. 4, Suppl. S, str. -
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
>> Sve godine

Ispis zapisa u formatu:TXT | BibTeX